TITLE

Randomised controlled trial of an automated, interactive telephone intervention to improve type 2 diabetes self-management (Telephone-Linked Care Diabetes Project): study protocol

AUTHOR(S)
Bird, Dominique; Oldenburg, Brian; Cassimatis, Mandy; Russell, Anthony; Ash, Susan; Courtney, Mary D.; Scuffham, Paul A.; Stewart, Ian; Wootton, Richard; Friedman, Robert H.
PUB. DATE
January 2010
SOURCE
BMC Public Health;2010, Vol. 10, p599
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: An estimated 285 million people worldwide have diabetes and its prevalence is predicted to increase to 439 million by 2030. For the year 2010, it is estimated that 3.96 million excess deaths in the age group 20-79 years are attributable to diabetes around the world. Self-management is recognised as an integral part of diabetes care. This paper describes the protocol of a randomised controlled trial of an automated interactive telephone system aiming to improve the uptake and maintenance of essential diabetes self-management behaviours. Methods/Design: A total of 340 individuals with type 2 diabetes will be randomised, either to the routine care arm, or to the intervention arm in which participants receive the Telephone-Linked Care (TLC) Diabetes program in addition to their routine care. The intervention requires the participants to telephone the TLC Diabetes phone system weekly for 6 months. They receive the study handbook and a glucose meter linked to a data uploading device. The TLC system consists of a computer with software designed to provide monitoring, tailored feedback and education on key aspects of diabetes self-management, based on answers voiced or entered during the current or previous conversations. Data collection is conducted at baseline (Time 1), 6-month follow-up (Time 2), and 12-month follow-up (Time 3). The primary outcomes are glycaemic control (HbA1c) and quality of life (Short Form-36 Health Survey version 2). Secondary outcomes include anthropometric measures, blood pressure, blood lipid profile, psychosocial measures as well as measures of diet, physical activity, blood glucose monitoring, foot care and medication taking. Information on utilisation of healthcare services including hospital admissions, medication use and costs is collected. An economic evaluation is also planned. Discussion: Outcomes will provide evidence concerning the efficacy of a telephone-linked care intervention for self-management of diabetes. Furthermore, the study will provide insight into the potential for more widespread uptake of automated telehealth interventions, globally. Trial Registration Number: ACTRN12607000594426
ACCESSION #
55100191

 

Related Articles

  • Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran. Javanbakht, Mehdi; Baradaran, Hamid R.; Mashayekhi, Atefeh; Haghdoost, Ali Akbar; Khamseh, Mohammad E.; Kharazmi, Erfan; Sadeghi, Aboozar // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Introduction Diabetes is a worldwide high prevalence chronic progressive disease that poses a significant challenge to healthcare systems. The aim of this study is to provide a detailed economic burden of diagnosed type 2 diabetes mellitus (T2DM) and its complications in Iran in 2009 year....

  • Type II diabetes patients in primary care: profiles of healthcare utilization obtained from observational data. van Dijk, Christel E.; Hoekstra, Trynke; Verheij, Robert A.; Twisk, Jos W. R.; Groenewegen, Peter P.; Schellevis, François G.; de Bakker, Dinny H. // BMC Health Services Research;2013, Vol. 13 Issue 1, p1 

    Background: The high burden of diabetes for healthcare costs and their impact on quality of life and management of the disease have triggered the design and introduction of disease management programmes (DMPs) in many countries. The extent to which diabetes patients vary with regard to their...

  • Estimated lifetime cost for diabetes higher for male patients. Brannon, Matthew; Kalvaitis, Katie; Southall, Jennifer // Endocrine Today;Jul2010, Vol. 8 Issue 7, p19 

    The article discusses a study which estimated the lifetime cost for a man or woman diagnosed with type 2 diabetes at age 50 years at 172,000 U.S. dollars utilizing a validated diabetes simulation model.

  • Prevention programs may delay type 2 diabetes development, lower health care costs.  // Endocrine Today;May2012, Vol. 10 Issue 5, p24 

    The article discusses research on the impact of prevention programs on type 2 diabetes development in patients and health care costs.

  • High costs of revascularisation difficult to recoup.  // PharmacoEconomics & Outcomes News;1/23/2010, Issue 595, p7 

    The article discusses research on the costs of prompt coronary revascularization in patients with type 2 diabetes mellitus with stable coronary disease, that references a study by M. A. Hlatky and colleagues published in the December 22, 2009 issue of "Circulation."

  • Hypoglycaemia exacts extra costs in Canada.  // PharmacoEconomics & Outcomes News;7/24/2010, Issue 608, p7 

    The article discusses research on the association of hypoglycemia with medication, discontinuation and costs in type 2 diabetes mellitus patients in Canada, referencing a study by M. Bron and colleagues presented at the 70th Annual Scientific Sessions of the American Diabetes Association.

  • Selecting optimal FPG threshold to identify high T2DM risk.  // PharmacoEconomics & Outcomes News;11/2/2013, Issue 690, p9 

    The article cites a study that appeared in an article by X Zhuo et al. in the October 17, 2013 issue of "Diabetes Care," showing that a lower fasting plasma glucose (FPG) region for naming the target population for type 2 diabetes mellitus prevention offers bigger benefits but higher cost per QALY.

  • The Direct Medical Cost of Type 2 Diabetes. Brandle, Michael; Zhou, Honghong; Smith, Barbara R.K.; Marriott, Deanna; Burke, Ray; Tabaei, Bahman P.; Brown, Morton B.; Herman, William H. // Diabetes Care;Aug2003, Vol. 26 Issue 8, p2300 

    OBJECTIVE — To describe the direct medical costs associated with type 2 diabetes, as well as its treatments, complications, and comorbidities. RESEARCH DESIGN AND METHODS — We studied a random sample of 1,364 subjects with type 2 diabetes who were members of a Michigan health...

  • Prevention programs may delay type 2 diabetes development, lower health care costs.  // Endocrine Today;May2012, Vol. 10 Issue 5, p24 

    The article discusses research on the impact of prevention programs on type 2 diabetes development in patients and health care costs.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics